Next Article in Journal
A Novel Anti-CD47 Nanobody Tetramer for Cancer Therapy
Next Article in Special Issue
Immunotherapy Strategy for Systemic Autoimmune Diseases: Betting on CAR-T Cells and Antibodies
Previous Article in Journal
Heterogeneity in Disulfide Bond Reduction in IgG1 Antibodies Is Governed by Solvent Accessibility of the Cysteines
Previous Article in Special Issue
Antibodies for β2-Microglobulin and the Heavy Chains of HLA-E, HLA-F, and HLA-G Reflect the HLA-Variants on Activated Immune Cells and Phases of Disease Progression in Rheumatoid Arthritis Patients under Treatment
 
 
Review

Article Versions Notes

Antibodies 2024, 13(1), 1; https://doi.org/10.3390/antib13010001
Action Date Notes Link
article xml file uploaded 2 January 2024 06:34 CET Original file -
article xml uploaded. 2 January 2024 06:34 CET Update -
article pdf uploaded. 2 January 2024 06:34 CET Version of Record https://www.mdpi.com/2073-4468/13/1/1/pdf-vor
article html file updated 2 January 2024 06:35 CET Original file -
article xml file uploaded 3 January 2024 01:39 CET Update -
article xml uploaded. 3 January 2024 01:39 CET Update -
article pdf uploaded. 3 January 2024 01:39 CET Updated version of record https://www.mdpi.com/2073-4468/13/1/1/pdf-vor
article html file updated 3 January 2024 01:40 CET Update -
article xml file uploaded 4 January 2024 02:52 CET Update -
article xml uploaded. 4 January 2024 02:52 CET Update https://www.mdpi.com/2073-4468/13/1/1/xml
article pdf uploaded. 4 January 2024 02:52 CET Updated version of record https://www.mdpi.com/2073-4468/13/1/1/pdf
article html file updated 4 January 2024 02:55 CET Update https://www.mdpi.com/2073-4468/13/1/1/html
Back to TopTop